A three-dimensional imaging pipeline for the detection of vasculogenic mimicry in mouse tumor models

Inside a growing tumor, cells face a desperate problem: they need a steady supply of oxygen and nutrients to survive, but they are often too far from the body's natural blood vessels to get them. To solve this, many tumors try to build their own network of pipes. For decades, scientists believed these new pipes were built by the body's own blood vessel cells, a process known as angiogenesis. However, a more unsettling discovery changed that view. Researchers found that in some aggressive cancers, the tumor cells themselves can change their shape and behavior to act like blood vessel cells. They line up to form hollow tubes that carry blood, effectively creating a private highway system for the tumor. This phenomenon is called vasculogenic mimicry. Because these self-made vessels allow tumors to grow larger and spread more easily, they are linked to poor outcomes for patients. Yet, confirming that these vessels actually exist and function inside a living tumor has been incredibly difficult, leaving scientists unsure of how common they are or how to stop them.

The standard way to look for these vessels in the past involved taking a thin slice of tumor tissue and staining it with two different dyes. One dye, called CD31, lights up normal blood vessel cells. The other, known as PAS, highlights a sugary coating found on the inside of blood vessels. The logic was simple: if a tube-like structure had the sugary coating but lacked the normal blood vessel cells, it must be a tumor-made vessel. However, this method has a major flaw. The sugary stain is not specific to blood vessels; it can also stick to other parts of the tumor, creating false alarms. Furthermore, looking at a single flat slice of tissue cannot prove that the tube is actually carrying blood or that it is truly empty of normal cells throughout its entire length. It is like trying to understand the layout of a city by looking at a single photograph of a street; you might miss the connections and the true nature of the buildings.

To get a clearer picture, a team of researchers developed a new way to see these structures in three dimensions. Instead of relying on thin slices, they worked with whole chunks of tumor tissue from mice. First, they injected a fluorescent dye into the mice's veins. This dye, made from tomato lectin, acts like a tracer that flows through any open, functioning blood vessel, lighting up the inside of the tubes. After the dye had circulated, the researchers removed the tumors and used a special chemical process to make the tissue transparent, a bit like turning a block of glass into a clear window. They then stained the tissue with a marker that highlights normal blood vessel cells. Finally, they used a powerful microscope that takes thousands of images from different angles to reconstruct the entire network of vessels inside the tumor in 3D.

When they applied this new method to various types of breast and lung cancer models, the results were striking. The old method, using the two dyes on flat slices, suggested that many vessels were tumor-made. However, the new 3D imaging revealed that most of those suspected vessels were not actually carrying blood. In fact, the researchers found that the traditional method overestimated the number of functional, tumor-made vessels by a large margin. In some cases, less than two percent of the structures that looked like tumor vessels in the old method were actually carrying blood. The new technique showed that while functional tumor-made vessels do exist, they are far less common than previously thought, and the old method was often mistaking other sugary structures for blood vessels.

The study did more than just correct the numbers; it provided the first convincing visual proof that these tumor-made vessels can indeed connect to the host's blood supply and carry blood. In several models, the researchers saw tumor-made tubes that were completely empty of normal blood vessel cells, yet they were filled with the fluorescent tracer, proving they were open and flowing. They even observed "mosaic" vessels, where normal blood vessel cells and tumor cells shared the same tube, and junctions where a tumor-made vessel connected directly to a normal one. To be absolutely certain that these vessels were lined by tumor cells and not by some other type of host cell, they used a special mouse model where all the mouse's own cells glowed green. They found vessels that were filled with the red tracer but had no green glow around them, confirming that the tumor cells themselves were the only ones lining those specific tubes.

This work establishes a new, more reliable standard for detecting these dangerous vessels. By showing that the old method was prone to error, the researchers have clarified what we need to look for to find them. The new 3D pipeline allows scientists to see the full structure of the tumor's blood supply, confirming which vessels are real and functional. This clarity is essential for developing new drugs. If scientists cannot accurately identify these vessels, they cannot design treatments to stop them. By providing a clear map of how these vessels form and function, this research offers a solid foundation for future therapies aimed at cutting off the tumor's self-made lifelines.